Peter H.R. Green is director of the Celiac Disease Center at Columbia University. He is Ivan and Phyllis Seidenberg Professor of Medicine at Columbia University and attending physician at the Columbia University Medical Center (New York-Presbyterian Hospital). He is also co-author of “Celiac Disease: A Hidden Epidemic.”
![](https://www.thetransmitter.org/wp-content/uploads/2016/07/Peter-copy1.jpg)
Peter H.R. Green
Phyllis & Ivan Seidenberg Professor of Medicine, Columbia University
Celiac Disease Center at Columbia University
From this contributor
Going gluten-free unlikely to help most people with autism
The presence of antibodies against a wheat protein may indicate that a child with autism would benefit from a gluten-free diet — but little data support this theory.
![](https://www.thetransmitter.org/wp-content/uploads/2016/07/20160726-glutenseeds1120.jpg)
Going gluten-free unlikely to help most people with autism
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.